Identification and characterization of a novel nonsecosteroidal vitamin D receptor ligand

Drug Development Research

Volumn 68, Issue 2, 2007, Pages 51-60

  Chen, Fang ^a   Su, Qin ^a   Torrent, Maricel ^a   Wei, Nan ^a   Peekhaus, Norbert ^a   McMasters, Daniel ^a   Fisher, John ^a   Glantschnig, Helmut ^a   Hodor, Paul ^a   Flores, Osvaldo ^a   Reszka, Alfred ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Nonsecosteroid; VDR target genes; Vitamin D receptor

Indexed keywords

ANDROGEN RECEPTOR; CALCITRIOL; CARRIER PROTEIN; ESTROGEN RECEPTOR; LIGAND; OSTEOCALCIN; PODOCARPIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR LIGAND 1; VITAMIN D RECEPTOR LIGAND 2;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERCALCEMIA; IMMUNOMODULATION; LIGAND BINDING; MALIGNANT NEOPLASTIC DISEASE; MINERAL METABOLISM; MOLECULAR DOCKING; MOUSE; NONHUMAN; OSTEOPOROSIS; PSORIASIS;

EID: 34547632399     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20165     Document Type: Article

References (26)

1. Abagyan R, Totrov M. 1994. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J Mol Biol 235:983-1002.
2. Boehm MF, Fitzgerald P, Zou A, Elgort MG, Bischoff ED. Mere L, Mais DE, Bissonnette RP, Heyman RA, Nadzan AM, Reichman M, Allegretto EA. 1999. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3. Chem Biol 6:265-275.
3. Bouillon R, Verlinden L, Eelen G, De Clereq P, Vandewalle M, Mathieu C, Verstuyf A. 2005. Mechanisms for the selective action of Vitamin D analogs. J Steroid Biochem Mol Biol 97:21-30.
4. Brown TR. 2004. Nonsteroidal selective androgen receptors modulators (SARMs): designer androgens with flexible structures provide clinical promise. Endocrinology 145:5417-5419.
5. Chen F, Knecht K, Leu C, Rutledge SJ, Scafonas A, Gambone C, Vogel R, Zhang H, Kasparcova V, Bai C, Harada S, Schmidt A, Reszka A, Freedman L. 2004. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol. J Steroid Biochem Mol Biol 91:247-257.
6. Hughes TR, Mao M, Jones AR, Burchard J, Marton MJ, Shannon KW, Lefkowitz SM, Ziman M, Schelter JM, Meyer MR, Kobayashi S, Davis C, Dai H, He YD, Stephaniants SB, Cavet G, Walker WL, West A, Coffey E, Shoemaker DD, Stoughton R, Blanchard AP, Friend SH, Linsley PS. 2001. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 19:342-347.
7. Liu M, Freedman LP. 1994. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors. Mol Endocrinol 8:1593-1604.
8. Ma Y, Khalifa B, Yee YK, Lu J, Memezawa A, Savkur RS, Yamamoto Y, Chintalacharuvu SR, Yamaoka K, Stavrook KR, Bramlett KS, Zeng QQ, Chandrasekhar S, Yu XP, Linebarger JH, Iturria SJ, Burris TP, Kato S, Chin WW, Nagpal S. 2006. Identification and characterization of nonealcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J Clin Invest 116:892-904.
9. Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G. 2005. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24al) null mouse. Endocrinology 146:825-834.
10. McDonnell DP. 2003. Mining the complexities of the estrogen signaling pathways for novel therapeutics. Endocrinology 144:4237-4240.
11. Mizwicki MT, Keidel D, Bula CM, Bishop JE, Zanello LP, Wurtz JM, Moras D, Norman AW. 2004. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2- vitamin D3 signaling. Proc Natl Acad Sci USA 101:12876-12881.
12. Moreno J, Krishnan AV, Feldman D. 2005. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer. J Steroid Biochem Mol Biol 97:31-36.
13. Nagpal S, Na S, Rathnachalam R. 2005. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662-687.
14. Peekhaus NT, Ferrer M, Chang T, Kornienko O, Schneeweis JE, Smith TS, Hoffman I, Mitnaul LJ, Chin J, Fischer PA, Blizzard TA, Birzin ET, Chan W, Inglese J, Strulovici B, Rohrer SP, Schaeffer JM. 2003. A beta-lactamase- dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format. Assay Drug Dev Technol 1:789-800.
15. Peleg S, Uskokovic M, Ahene A, Vickery B, Avnur Z. 2002. Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats. Endocrinology 143:1625-1636.
16. Plum LA, Prahl JM, Ma X, Sicinski RR, Gowlugari S, Clagett-Dame M, DeLuca HF. 2004. Biologically active noncalcemic analogs of 1alpha,25-dihydroxwitamin D with an abbreviated side chain containing no hydroxvl. Proc Natl Acad Sci USA 101:6900-6904.
17. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, Liebhaber SA, Cooke NE. 1999. Osteopathy and resistance to
18. vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 103:239-251.
19. Shevde NK, Plum LA, Clagett-Dame M, Yamamoto H, Pike JW, DeLuca HF. 2002. A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation. Proc Natl Acad Sci USA 99:13487-13491.
20. Sutton AL, MacDonald PN. 2003. Vitamin D: more than a "bone-a-fide" hormone. Mol Endocrinol 17:777-791.
21. Valrance ME, Welsh J. 2004. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor. J Steroid Biochem Mol Biol 89-90:221-225.
22. van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA. 2001. Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Enkaryot Gene Expr 11:199-226.
23. Wang R, Lu Y, Wang S, 2003. Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem 46:2287-2303.
24. Weng L, Dai H, Zhan Y, He Y, Stepaniants SB, Bassett DE. 2006. Rosetta error model for gene expression analysis. Bioinformatics 22:1111-1121.
25. Wesolowski G, Duong LT, Lakkakorpi PT, Nagy RM, Tezuka K, Tanaka H, Rodan GA, Rodan SB. 1995. Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp Cell Res 219:679-686.
26. Zandbergen F, Mandard S, Escher P, Tan NS, Patsouris D, Jatkoe T, Rojas-Caro S, Madore S, Wahli W, Tafuri S, Muller M, Kersten S. 2005. The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem J 392:313-324.